Penn Undergraduate Law Journal
  • Home
  • About
    • Mission
    • Masthead
    • Faculty Advisory Board
    • Partner Journals
    • Sponsors
  • Submissions
  • Full Issues
  • The Roundtable
    • Pre-Law Corner
  • Events
  • Contact
    • Contact
    • Apply
    • FAQs
  • Home
  • About
    • Mission
    • Masthead
    • Faculty Advisory Board
    • Partner Journals
    • Sponsors
  • Submissions
  • Full Issues
  • The Roundtable
    • Pre-Law Corner
  • Events
  • Contact
    • Contact
    • Apply
    • FAQs

The Roundtable


Welcome to the Roundtable, a forum for incisive commentary and analysis
on cases and developments in law and the legal system.


INTERESTED IN wRITING FOR tHE rOUNDTABLE?

Drug Patenting and Access to Medicine: A Balancing Act

4/17/2017

0 Comments

 
Picture
By Harshit Rai
Harshit Rai is a third year student at the Symbiosis Law School, Pune.

Access to essential medicines is an iota of the larger mandate of health under various international declarations and conventions. The right to health is the right of all individuals to enjoy the highest attainable standard of physical and mental health. However, access to Medicines in general and life-saving essential drugs in particular is an issue of grave concern across the world. The shortage is particularly rampant in African and Asian underdeveloped countries where economic profiles are low and disease count high. Unlike the developed world where health insurance is common practice, majority people depend on their personal budget to meet health expenses. This has a severe effect when it comes to life threatening diseases.

Advancements in medical science have enabled the treatment of life threatening diseases through drug therapy. HIV, for instance, is treated using a combination of medicines too. This is called antiretroviral therapy (ART). ART isn’t a complete cure, but it can control the virus, which enables one to live a longer, healthier life and reduce the risk of transmitting HIV to others. ART involves taking a combination of HIV medicines every day, exactly as prescribed. [1]

Drug patenting becomes one of the biggest impediments affecting accessibility to medicines. A patent grants a virtual monopoly to a pharmaceutical company on a particular drug, allowing it to ascertain the price of the drug. This is often at exorbitant rates, rendering it unaffordable for the majority of populations.

The TRIPS agreement mandates that basic patenting standards are maintained by all countries and includes a special transition arrangement operating for counties which do not presently provide product patent protection in the area of pharmaceuticals. [2] International Patent law however, does let countries decide the method of implementation of patent laws in their respective jurisdictions and provide exceptions to the same.
In India, Section 3(d) of the Indian Patent Act, 1970 (as amended in 2005) does not allow patent to be granted to inventions involving new forms of a known substance unless it differs significantly in properties with regard to efficacy. Thus, the Indian Patent Act does not allow evergreening of patents. This has become a matter of concern to the US pharma companies, and Section 3(d) has turned out be a highly criticised patent provision by India. [3] This provision allows patents on variants of only those chemical compounds that show significant enhancement in “therapeutic efficacy,” which is a significant barrier against the monopoly of the multinational drugs. [4]

The Provision can be envisaged to protect the interests of the patient who are dependent on inexpensive generic drugs. Patented drugs are much highly priced than generic drugs and Section 3(d) restricts patenting of pharmaceutical inventions with minor changes and patent expired drugs, while helping balance public goods with improved access of medicine to citizens. [5]

Prices are skyrocketing for the prescribed period as patent-holders seek to maximize returns on their investment and increase profits. For instance, costs of patented drugs which combat the HIV virus are enormous. A month’s worth of Atripla, an anti-HIV drug, costs US$1,300. Such prices are only affordable in industrialized countries due to governmental benefits, which are not available in the developing world. Clearly, it is impossible for most people in the developing world, where most HIV cases arise, to pay such prices. The result is a stark health dichotomy, while HIV remains a death sentence for most sufferers in the developing world, it can be managed for many years by sufferers in the developed world who have access to medication.[6]

However, patents cannot be branded as the main culprits in the quest of access to medicines. The suffering in the developing world will not be alleviated without a global commitment of the world to finance health improvements. As developing countries historically do not have the necessary resources and/or will to finance such an initiative, advanced industrialized countries must take on more responsibility and lead the way in funding the restructuring of the current inadequate medical infrastructure.
There is a need for effective accountability mechanisms to ensure compliance by pharmaceutical companies to their human rights obligations.  Civil society organisations can also take the lead in this regard. Panels can be appointed, to monitor the policies and practices of pharmaceutical companies and hold them publicly accountable for the discharge of their right-to-health responsibilities. [7]






1.      How is Hiv Treated ? https://www.aids.gov/hiv-aids-basics/just-diagnosed-with-hiv-aids/treatment-options/overview-of-hiv-treatments/
2.     Overview: the TRIPS Agreement https://www.wto.org/english/tratop_e/trips_e/intel2_e.htm
3.      US Opposition to Section 3(D) of the Indian Patent Act http://pib.nic.in/newsite/PrintRelease.aspx?relid=107612
4.      Section 3(d) implications and key concerns of pharmaceutical sector http://nopr.niscair.res.in/bitstream/123456789/34013/1/JIPR%2021(1)%2016-26.pdf
5.      Ibid
6. TRIPS and the Right to Health http://www.oxfordscholarship.com/view/10.1093/acprof:oso/9780199565894.001.0001/acprof-9780199565894-chapter-8
7.      Hunt P, Khosla R (2010) Are Drug Companies Living Up to Their Human Rights Responsibilities? The Perspective of the Former United Nations Special Rapporteur (2002-2008). http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000330



0 Comments

Your comment will be posted after it is approved.


Leave a Reply.


    Categories

    All
    Akshita Tiwary
    Alana Bess
    Alana Mattei
    Albert Manfredi
    Alexander Saeedy
    Alexandra Aaron
    Alexandra Kanan
    Alice Giannini
    Alicia Augustin
    Alicia Kysar
    Ally Kalishman
    Ally Margolis
    Alya Abbassian
    Anika Prakash
    Anna Schwartz
    Ashley Kim
    Astha Pandey
    Audrey Pan
    Benjamin Ng'aru
    Brónach Rafferty
    Bryce Klehm
    Cary Holley
    Christina Gunzenhauser
    Christine Mitchell
    Christopher Brown
    Clarissa Alvarez
    Cole Borlee
    Connor Gallagher
    Dan Spinelli
    Dan Zhang
    David Katz
    Davis Berlind
    Derek Willie
    Dhilan Lavu
    Edgar Palomino
    Edna Simbi
    Ella Sohn
    Emma Davies
    Esther Lee
    Evelyn Bond
    Filzah Belal
    Frank Geng
    Gabriel Maliha
    Georgia Ray
    Graham Reynolds
    Habib Olapade
    Hailie Goldsmith
    Haley Son
    Harshit Rai
    Henry Lininger
    Hetal Doshi
    Iris Zhang
    Irtaza Ali
    Isabela Baghdady
    Ishita Chakrabarty
    Jack Burgess
    Jessica "Lulu" Lipman
    Joe Anderson
    Jonathan Lahdo
    Jonathan Stahl
    Joseph Squillaro
    Justin Yang
    Kaitlyn Rentala
    Kanishka Bhukya
    Katie Kaufman
    Kelly Liang
    Keshav Sharma
    Ketaki Gujar
    Lauren Pak
    Lavi Ben Dor
    Libby Rozbruch
    Lindsey Li
    Luis Bravo
    Lyndsey Reeve
    Madeline Decker
    Maja Cvjetanovic
    Maliha Farrooz
    Marco DiLeonardo
    Margaret Lu
    Matthew Caulfield
    Michael Keshmiri
    Mina Nur Basmaci
    Muskan Mumtaz
    Natalie Peelish
    Natasha Darlington
    Natasha Kang
    Nayeon Kim
    Nicholas Parsons
    Nicholas Williams
    Nicole Greenstein
    Nihal Sahu
    Omar Khoury
    Owen Voutsinas Klose
    Owen Voutsinas-Klose
    Pheby Liu
    Rachel Bina
    Rachel Gu
    Rachel Pomerantz
    Rebecca Heilweil
    Regina Salmons
    Sajan Srivastava
    Sandeep Suresh
    Sanjay Dureseti
    Sarah Simon
    Saranya Das Sharma
    Saranya Sharma
    Sasha Bryski
    Saxon Bryant
    Sean Foley
    Sebastian Bates
    Serena Camici
    Shahana Banerjee
    Shannon Alvino
    Shiven Sharma
    Siddarth Sethi
    Sneha Parthasarathy
    Sneha Sharma
    Sophie Lovering
    Steven Jacobson
    Suaida Firoze
    Suprateek Neogi
    Takane Shoji
    Tanner Bowen
    Taryn MacKinney
    Thomas Cribbins
    Todd Costa
    Tyler Larkworthy
    Vatsal Patel
    Vikram Balasubramanian
    Vishwajeet Deshmukh
    Wajeeha Ahmad
    Yeonhwa Lee

    Archives

    March 2023
    January 2023
    December 2022
    November 2022
    September 2022
    June 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    May 2019
    April 2019
    March 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    December 2017
    November 2017
    October 2017
    August 2017
    July 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    April 2016
    March 2016
    February 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    November 2014
    October 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    December 2013
    November 2013
    October 2013
    September 2013

Picture
Picture
​